Jhonson and Johnson Strategic Analysis Process

Customers make demands on the market by routinely expressing their desire for “more”. This has been called “seeking a bigger and better deal”. The demand is for more value, and more options. As they search the marketplace for its offerings, customers are often pleased to see new suppliers. They consider the new offerings, and make decisions about changing their purchasing habits.

Before we can talk about the Strategy Hudson Bay uses we must first answer the the question of what a Corporate and Business Strategy is and how The Bay inaugurates this into their company;

As we can see, both alternatives imply as well opportunities and risks. If I were the decision maker in this case I would surely choose the alternative to implement the new technology that will allow the company to create innovative products.

The external environment consists of opportunities and threats. J&J can greatly benefit from taking advantage of opportunities. An opportunity that J&J can benefit from is the changes in Medicare insurance that have recently been enacted providing increased medical coverage to seniors with Medicare by covering prescription drugs. An article that I read in the Wall Street Journal stated that the new plan increases prescription drug coverage for senior citizens dramatically. This should increase the amount of prescription drug use in the U.S. Since pharmaceutical sales is J&J's largest segment, increases in prescription drug use can potentially increase sales and profits for

It plays a great role in changing the psychology of consumers to convince them to switch brands

The medical world has noticed several changes and improvements during the past century, but maybe none that 's as economically rewarding afterward the prescription drug business. New medications turn-up regular and maintain to treat a growing number of ailments. Around the corner of each and every block is a drugstore as well as their shelves are stocked with prescription drugs plus it looks they 're here to stay. Most frequently we change to

Risk sharing is one of the circumstance why MNEs form JV, it is commonly practiced in industries that require high capital and where the cost of developing a product is very high (Zhou and Li 2008). IJVs allows to gain rapid entry into a new industry and to benefit from synergies to develop a new product or technology (Dr. Ananthram. 2016). For example NEC-AT&T.

The organizations that will be discussed are Century 21 Powerhouse Realty where I am employed at as a real estate agent and the Disney organization, which is an organization that has adopted total quality management. In the following paragraphs I will evaluate my organization’s mission, vision, goals, and objectives as well as discuss the relationship

The risk of generic substitution is also increasing with especially China dominating the production market. Customers will substitute for a generic product if the disposable incomes of the customers reduce resulting in customers willing to trade down for a inferior but cheaper product.

* Patent Expiration - in the next four years, the two highest sales producing pharmaceutical products will go off patent. Patents on Merck’s Cozaar and Singulair will expire in February 2010 and August 2012, respectively, exposing about $8.2 billion worth of sales to generic competition. This equates to about 35% of Merck’s forecasted revenue in 2012 [and 29% of 2009 revenues].

The threat of substitutes for the Household Products of the Nondurables Industry is high. As mentioned before, each company produces a product that is very similar to its competitors. Customers also have high bargaining power in that they can buy substitute products such as paper towels and disinfecting sprays. If a company does not spend time and effort marketing its products, consumers will not be able to differentiate them from a competitor.

This enabled numerous “me too” drugs to achieve satisfactory returns on investment. Imitating a known drug reduced R&D risk considerably, while the marketplace was open to products offering minor advantages such as a more convenient dosage with fewer side effects, but with much the same therapeutic outcome. Generics legislation had a major impact on the industry, providing incentives for innovation and a race to market. The time during which R&D costs could be recouped was drastically curtailed, putting upward pressure on prices. By the end of the 1970s generic entrants and more stringent controls on clinical trials had led to substantial increases in R&D spending.

The threat of substitutes: where it refers to substitute product as those that are available in other industry which can also fulfil the need and want of the consumers. It can affect competition in an industry by placing an invisible ceiling on prices which companies within the industry can charge, due to the fact that if the cost of substitute is low then the consumers will tend to purchase substitutes, therefore limiting the prices that a company can place on certain items to gain maximum profit. For example, lemonade can be substituted for a soft drink. Generally, competitive pressures arising from substitute products increase as the relative price of substitute products declines and as consumer 's switching costs decrease.

It gives the consumer an alternative to buy products that have still not saturated the market.

To establish whether JKB is competitively positioned to tackle the evolving and increasing challenging business environment hence recommend the way forward, a situation analysis must be conducted. This analysis aids in collecting essential information about the organization internal and external factors. Keen interest should be placed on these factors since they have the capability of adversely affecting an organization; they can create or on the other diminish, or altogether destroy the chances of an organization attaining competitive advantage.